In the meantime, the availability of the two highest-dose Zepbound vials gives providers and patients another important treatment option."(Source: Eli Lilly & Co., June 2025) Ozempic captures close to 60% of the GLP-1 receptor agonist category, underscoring its lead among semaglutide-based therapies
Bioinformatics analysis for constructing a cellular senescence-related age-related macular degeneration diagnostic model and identifying relevant disease subtypes to guide treatment
To assess allulose effects on glycemic parameters in response to an oral glucose tolerance test with 75 g of D-glucose or defined test meals, several studies have been performed in both healthy individuals and individuals with pre-diabetes or overt type 2 diabetes
10.1021/jacs.9b05365 [DOI] [PMC free article] [PubMed] [Google Scholar] Liang, Y.L
The most significant improvements occurred between 12 and 18 months
Ipamorelin offers a way to push back against this decline